The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 28, 2022

Filed:

May. 10, 2018
Applicant:

The Board of Trustees of the Leland Stanford Junior University, Stanford, CA (US);

Inventors:

Paul A. Wender, Stanford, CA (US);

Katherine N. Keenan, Stanford, CA (US);

Nancy Lynn Benner, Stanford, CA (US);

Jack Leider Sloane, Stanford, CA (US);

Xiaoyu Zang, Stanford, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 69/013 (2006.01); A61P 31/18 (2006.01); C07C 69/78 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
C07C 69/013 (2013.01); A61P 31/18 (2018.01); C07C 69/78 (2013.01); A61K 9/007 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); C07C 2603/40 (2017.05);
Abstract

Embodiments of prodrugs of PKC modulators that show efficacy coupled with low levels of toxicity and improved stability are provided. The prodrug compounds are useful in academic research (animal studies), as candidates for preclinical research, and as therapeutic agents. By taking advantage of a pharmacophore-based strategy, this design strategy provides access to prodrugs of PKC modulators of diverse scaffolds including tigliane diterpenes, ingenane diterpenes, daphnane diterpene orthoesters, diacylglycerols, and bryostatins, and analogs thereof. In particular, embodiments of the prodrug ingenane esters having substitutions at C20 and their use as therapeutic agents are provided.


Find Patent Forward Citations

Loading…